EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach

Derek VanDyke, Linda Xu, Paul R Sargunas, Ryan N Gilbreth, Manuel Baca, Changshou Gao, James Hunt, Jamie B Spangler

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Derek VanDyke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA; Translational Tissue Engineering Center, Joh…. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, National Institutes of Health, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hijacking the ubiquitin proteasome system to elicit targeted protein degradation (TPD) has emerged as a promising therapeutic strategy to target and destroy intracellular proteins at the post-translational level. Small molecule-based TPD approaches, such as proteolysis-targeting chimeras (PROTACs) and molecular glues, have shown potential, with several agents currently in clinical trials. Biological PROTACs (bioPROTACs), which are engineered fusion proteins comprised of a target-binding domain and an E3 ubiquitin ligase, have emerged as a complementary approach for TPD. Here, we describe a new method for the evolution and design of bioPROTACs. Specifically, engineered binding scaffolds based on the third fibronectin type III domain of human tenascin-C (Tn3) were installed into the E3 ligase tripartite motif containing-21 (TRIM21) to redirect its degradation specificity. This was achieved via selection of naïve yeast-displayed Tn3 libraries against two different oncogenic proteins associated with B-cell lymphomas, mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) and embryonic ectoderm development protein (EED), and replacing the native substrate-binding domain of TRIM21 with our evolved Tn3 domains. The resulting TRIM21-Tn3 fusion proteins retained the binding properties of the Tn3 as well as the E3 ligase activity of TRIM21. Moreover, we demonstrated that TRIM21-Tn3 fusion proteins efficiently degraded their respective target proteins through the ubiquitin proteasome system in cellular models. We explored the effects of binding domain avidity and E3 ligase utilization to gain insight into the requirements for effective bioPROTAC design. Overall, this study presents a versatile engineering approach that could be used to design and engineer TRIM21-based bioPROTACs against therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexProteinsHumansUbiquitin-Protein LigasesProteolysisUbiquitinationUbiquitin

Stichwörter der Autor:innen

E3 ubiquitin ligaseTRIM21bioPROTACdirected evolutionlymphomaprotein degradationscaffold proteintargeted protein degradation

Substanzen

Proteasome Endopeptidase ComplexProteinsUbiquitin-Protein LigasesUbiquitin

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Bi…
  • Biologics Engineering, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.
  • Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Bl…

Förderung

  • NIBIB NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense
  • National Science Foundation Office of the Director
  • Johns Hopkins University
  • ARCS Foundation Inc
  • National Science Foundation

Zitieren

APA

VanDyke, D., Xu, L., Sargunas, P. R., Gilbreth, R. N., Baca, M., Gao, C., Hunt, J., & Spangler, J. B. (2023). Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105381

Vancouver

VanDyke D, Xu L, Sargunas PR, Gilbreth RN, Baca M, Gao C, et al. Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105381

BibTeX
@article{VanDyke2023,
  author = {VanDyke, Derek and Xu, Linda and Sargunas, Paul R and Gilbreth, Ryan N and Baca, Manuel and Gao, Changshou and Hunt, James and Spangler, Jamie B},
  title = {Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105381}
}
Kostenlos starten →